Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Non-Small Cell Lung Cancer (NSCLC) Workup: Approach Considerations, Laboratory Studies, Chest Radiography
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway | Cell Communication and Signaling | Full Text
Activation mechanism of the μ-opioid receptor by an allosteric modulator | PNAS
The Role of Opioids and Their Receptors in Urological Malignancy: A Review
Psychoactives | Free Full-Text | The Role of the Dynorphin/Kappa Opioid Receptor System in the Actions of Alcohol
Opioids in cancer: The κ‑opioid receptor (Review)
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation - ScienceDirect
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
IJMS | Free Full-Text | Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
Kappa opioid receptor (KOR) modulation of dopamine in the cortex and... | Download Scientific Diagram
Frontiers | Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction? | Current Oncology Reports
Opioid receptor subtypes: fact or artifact? - British Journal of Anaesthesia
Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer | Cancer Biology & Medicine
Pharmaceuticals | Free Full-Text | Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction
Biomedicines | Free Full-Text | δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target - British Journal of Anaesthesia
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells | British Journal of Cancer
IJMS | Free Full-Text | The Downregulation of Opioid Receptors and Neuropathic Pain
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Untangling the complexity of opioid receptor function | Neuropsychopharmacology
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Opioids in cancer: The κ‑opioid receptor (Review)
2023 News - Structure of Opioid Receptors May Reveal How to Better Design Pain Relievers, Addiction Therapies | University of Maryland School of Medicine
